Ptc Therapeutics (PTCT) EBT (2016 - 2025)
Historic EBT for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to -$23.1 million.
- Ptc Therapeutics' EBT rose 7645.29% to -$23.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $505.3 million, marking a year-over-year increase of 19829.02%. This contributed to the annual value of -$598.8 million for FY2024, which is 2369.4% up from last year.
- According to the latest figures from Q3 2025, Ptc Therapeutics' EBT is -$23.1 million, which was up 7645.29% from -$71.1 million recorded in Q2 2025.
- Over the past 5 years, Ptc Therapeutics' EBT peaked at $929.8 million during Q1 2025, and registered a low of -$330.4 million during Q4 2024.
- In the last 5 years, Ptc Therapeutics' EBT had a median value of -$128.2 million in 2021 and averaged -$87.2 million.
- Its EBT has fluctuated over the past 5 years, first tumbled by 18195.93% in 2021, then surged by 119784.17% in 2025.
- Quarter analysis of 5 years shows Ptc Therapeutics' EBT stood at -$138.6 million in 2021, then crashed by 39.48% to -$193.3 million in 2022, then decreased by 27.08% to -$245.7 million in 2023, then tumbled by 34.48% to -$330.4 million in 2024, then soared by 93.02% to -$23.1 million in 2025.
- Its last three reported values are -$23.1 million in Q3 2025, -$71.1 million for Q2 2025, and $929.8 million during Q1 2025.